This 2016 review explains how obesity and metabolic syndrome (MetS) impair immune function at multiple levels. Excess nutrient intake leads to adipose tissue stress, chronic low-grade inflammation, insulin resistance, and systemic metabolic disruption. These changes alter immune cell behavior, skewing leukocyte populations toward proinflammatory phenotypes while simultaneously weakening effective pathogen defense.
The authors describe how obesity increases fat deposition in primary lymphoid organs such as the bone marrow and thymus, disrupting tissue architecture and reducing proper T-cell development. Obesity also shifts immune balance toward inflammatory macrophages and T-helper cell profiles, elevates white blood cell counts, and impairs coordination between innate and adaptive immunity. Despite heightened baseline inflammation, individuals with obesity show reduced vaccine efficacy, impaired immune memory, and greater susceptibility to infections such as influenza and sepsis.
Overall, the review highlights a paradox: obesity promotes chronic inflammation while simultaneously weakening immune competence, increasing the risk of both metabolic disease progression and infectious complications.